Skip to main content
padlock icon - secure page this page is secure

Efficacy and tolerance of GELOXD/P‐GEMOXD in newly diagnosed nasal‐type extranodal NK/T‐cell lymphoma: A multicenter retrospective study

Buy Article:

$59.00 + tax (Refund Policy)

Nasal‐type extranodal natural killer NK/T‐cell lymphoma (ENKTCL) is a distinct type of non‐Hodgkin lymphoma with poor prognosis. This research aimed to evaluate the efficacy and safety of the GELOXD or P‐GEMOXD regimens in patients with ENKTCL.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: asparaginase; efficacy; nasal‐type extranodal NK/T‐cell lymphoma; tolerance

Document Type: Research Article

Publication date: March 1, 2018

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more